Work

27468 Bimekizumab short-term and longer-term infection rates in patients with moderate to severe plaque psoriasis: Analysis of pooled data from eight phase 2/3 clinical trials

Year: 2021

Type: article

Source: Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2021.06.598

Authors: Kristian Reich, Yukari Okubo, Kenneth B. Gordon, Andrew Blauvelt, April Armstrong, Dirk De Cuyper, Christopher Cioffi, Luke Peterson, Mark Lebwohl

Institutions: University Medical Center Hamburg-Eppendorf, Tokyo Medical University, Medical College of Wisconsin, Oregon Medical Research Center, University of Southern California, UCB Pharma (Belgium), Icahn School of Medicine at Mount Sinai

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3193765042

FWCI:

Cites:

Cited by:

Related to: 10